Skip to main content
Journal cover image

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

Publication ,  Journal Article
Sperduto, PW; Yang, TJ; Beal, K; Pan, H; Brown, PD; Bangdiwala, A; Shanley, R; Yeh, N; Gaspar, LE; Braunstein, S; Sneed, P; Boyle, J; Mak, KS ...
Published in: Int J Radiat Oncol Biol Phys
October 1, 2016

PURPOSE: Lung cancer remains the most common cause of both cancer mortality and brain metastases (BM). The purpose of this study was to assess the effect of gene alterations and tyrosine kinase inhibition (TKI) on median survival (MS) and cause of death (CoD) in patients with BM from lung adenocarcinoma (L-adeno). METHODS: A multi-institutional retrospective database of patients with L-adeno and newly diagnosed BM between 2006 and 2014 was created. Demographics, gene alterations, treatment, MS, and CoD were analyzed. The treatment patterns and outcomes were compared with those in prior trials. RESULTS: Of 1521 L-adeno patients, 816 (54%) had known alteration status. The gene alteration rates were 29%, 10%, and 26% for EGFR, ALK, and KRAS, respectively. The time from primary diagnosis to BM for EGFR-/+ was 10/15 months (P=.02) and for ALK-/+ was 10/20 months (P<.01), respectively. The MS for the group overall (n=1521) was 15 months. The MS from first treatment for BM for EGFR and ALK-, EGFR+, ALK+ were 14, 23 (P<.01), and 45 (P<.0001) months, respectively. The MS after BM for EGFR+ patients who did/did not receive TKI before BM was 17/30 months (P<.01), respectively, but the risk of death was not statistically different between TKI-naïve patients who did/did not receive TKI after the diagnosis of BM (EGFR/ALK hazard ratios: 1.06 [P=.84]/1.60 [P=.45], respectively). The CoD was nonneurologic in 82% of patients with known CoD. CONCLUSION: EGFR and ALK gene alterations are associated with delayed onset of BM and longer MS relative to patients without these alterations. The CoD was overwhelmingly nonneurologic in patients with known CoD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Int J Radiat Oncol Biol Phys

DOI

EISSN

1879-355X

Publication Date

October 1, 2016

Volume

96

Issue

2

Start / End Page

406 / 413

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Risk Factors
  • Retrospective Studies
  • Receptor Protein-Tyrosine Kinases
  • Protein-Tyrosine Kinases
  • Prevalence
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Mutation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sperduto, P. W., Yang, T. J., Beal, K., Pan, H., Brown, P. D., Bangdiwala, A., … Mehta, M. P. (2016). The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys, 96(2), 406–413. https://doi.org/10.1016/j.ijrobp.2016.06.006
Sperduto, Paul W., T Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, et al. “The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.Int J Radiat Oncol Biol Phys 96, no. 2 (October 1, 2016): 406–13. https://doi.org/10.1016/j.ijrobp.2016.06.006.
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, et al. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):406–13.
Sperduto, Paul W., et al. “The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.Int J Radiat Oncol Biol Phys, vol. 96, no. 2, Oct. 2016, pp. 406–13. Pubmed, doi:10.1016/j.ijrobp.2016.06.006.
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):406–413.
Journal cover image

Published In

Int J Radiat Oncol Biol Phys

DOI

EISSN

1879-355X

Publication Date

October 1, 2016

Volume

96

Issue

2

Start / End Page

406 / 413

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Risk Factors
  • Retrospective Studies
  • Receptor Protein-Tyrosine Kinases
  • Protein-Tyrosine Kinases
  • Prevalence
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Mutation